Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             32 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Advanced Hodgkin lymphoma in the East of England: a 10-year comparative analysis of outcomes for real-world patients treated with ABVD or escalated-BEACOPP, aged less than 60 years, compared with 5-year extended follow-up from the RATHL trial Russell, James

100 4 p. 1049-1058
artikel
2 Age-dependent increase of treatment-related mortality in older patients with aggressive B cell lymphoma: analysis of outcome, treatment feasibility, and toxicity in 1171 elderly patients with aggressive B cell lymphoma—data from phase II and III trials of the DSHNHL (German High-Grade Non-Hodgkin’s Lymphoma Study Group) Zettl, Florian

100 4 p. 1031-1038
artikel
3 Alpha thalassemia, but not βS-globin haplotypes, influence sickle cell anemia clinical outcome in a large, single-center Brazilian cohort Hatzlhofer, Betânia Lucena Domingues

100 4 p. 921-931
artikel
4 Ambulatory high-dose methotrexate administration as central nervous system prophylaxis in patients with aggressive lymphoma Bernard, S.

100 4 p. 979-986
artikel
5 Anti-CD19 CAR-T cell therapy bridge to HSCT decreases the relapse rate and improves the long-term survival of R/R B-ALL patients: a systematic review and meta-analysis Hu, Linhui

100 4 p. 1003-1012
artikel
6 CD3+/CD56+ EBV+ neoplasms in the nose and upper aerodigestive tract: potential misdiagnosis of plasma cell malignancies as NK/T cell lymphoma Au-Yeung, Rex

100 4 p. 1101-1104
artikel
7 Circulating low CD4+/CD8+ ratio is associated with poor prognosis in Waldenstrom macroglobulinemia patients Cao, Xin

100 4 p. 995-1002
artikel
8 Comparison of myeloablative and reduced intensity conditioning unrelated donor allogeneic peripheral blood stem cell transplant outcomes for AML using thymoglobulin for GVHD prophylaxis Modi, Dipenkumar

100 4 p. 969-978
artikel
9 Curcuminoids supplementation ameliorates iron overload, oxidative stress, hypercoagulability, and inflammation in non-transfusion-dependent β-thalassemia/Hb E patients Hatairaktham, Suneerat

100 4 p. 891-901
artikel
10 Cure rate in the elderly patients with diffuse large B cell lymphoma deteriorates after the age of 80—results from a single-center survey Freudenberger, Felix

100 4 p. 1013-1021
artikel
11 Daratumumab in multiple myeloma: experience of the multiple myeloma GIMEMA Lazio group Vozella, Federico

100 4 p. 1059-1063
artikel
12 Dynamic evaluation of the prognostic value of 18F-FDG PET/CT in extranodal NK/T-cell lymphoma, nasal type Xu, Pengpeng

100 4 p. 1039-1047
artikel
13 Effectiveness and safety of tacrolimus with or without eltrombopag, as a part of immunosuppressive treatment of aplastic anemia in adults: a retrospective case series Martynova, Anastasia

100 4 p. 933-939
artikel
14 Frequent occurrence of hypophosphatemia among multiple myeloma patients treated with elotuzumab: a single clinic retrospective study Regidor, Bernard

100 4 p. 1079-1085
artikel
15 Hepcidin and other indicators of iron status, by alpha-1 acid glycoprotein levels, in a cohort of Mexican infants Mendoza, Eugenia

100 4 p. 879-890
artikel
16 IgM-MGUS and associated membranoproliferative glomerulonephritis during IVIG administration Ruhe, Johannes

100 4 p. 1087-1088
artikel
17 Influence of UGT1A1 promoter polymorphism, α-thalassemia and βs haplotype in bilirubin levels and cholelithiasis in a large sickle cell anemia cohort Batista, Jéssica V. G. F.

100 4 p. 903-911
artikel
18 Long-term follow-up of a prospective phase 2 clinical trial of extended treatment with rituximab in patients with B cell post-transplant lymphoproliferative disease and validation in real world patients González-Barca, Eva

100 4 p. 1023-1029
artikel
19 Numb chin syndrome in sickle cell disease: a case series of Jamaican patients Ramsay, Zachary

100 4 p. 913-919
artikel
20 Post-transplantation lymphoproliferative disorder after haematopoietic stem cell transplantation Pegoraro, Francesco

100 4 p. 865-878
artikel
21 Real-world outcomes following venetoclax therapy in patients with chronic lymphocytic leukemia or Richter syndrome: a FILO study of the French compassionate use cohort Bouclet, Florian

100 4 p. 987-993
artikel
22 Revealing the true face behind the mask of ALK-positive anaplastic large cell lymphoma (ALCL) Eisfeld, Hannah

100 4 p. 1107-1109
artikel
23 Risk factors for monoclonal gammopathy of undetermined significance: a systematic review Castaneda-Avila, Maira A.

100 4 p. 855-863
artikel
24 Ruxolitinib treatment improves muscle mass in patients with myelofibrosis Lucijanic, Marko

100 4 p. 1105-1106
artikel
25 Single-drug vinorelbine as a salvage re-induction regimen for 4 consecutive pediatric patients with relapsed anaplastic large-cell lymphoma in a single children’s institution Yuan, Qing

100 4 p. 1093-1095
artikel
26 Strongyloides stercoralis hyperinfection syndrome in mantle cell lymphoma in post-transplant setting Sahu, Kamal Kant

100 4 p. 1089-1091
artikel
27 Subcutaneous daratumumab in Asian patients with heavily pretreated multiple myeloma: subgroup analyses of the noninferiority, phase 3 COLUMBA study Iida, Shinsuke

100 4 p. 1065-1077
artikel
28 Successful treatment of EBV-related lymphoproliferative disease after heart transplantation with autologous hematopoietic stem cell transplantation despite transient heart failure associated with engraftment syndrome Yasunaga, Megumi

100 4 p. 1097-1100
artikel
29 Temporal trends and outcome of splenectomy in adults with immune thrombocytopenia in the USA Finianos, Antoine

100 4 p. 941-952
artikel
30 The prognostic value of the Fibrinogen-Albumin Ratio Index in patients with myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes treated with azacitidine Akimoto, Masahiro

100 4 p. 953-957
artikel
31 Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group Schuler, Esther

100 4 p. 959-968
artikel
32 Venetoclax and azacytidine combination is an effective bridge to transplant strategy in relapsed/refractory acute myeloid leukemia patients Zappasodi, P.

100 4 p. 1111-1113
artikel
                             32 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland